Trial
NCT00294723
To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Novo Nordisk A/S
Collaborators
—
Condition
Diabetes
Intervention
liraglutide
Why stopped
The trial was terminated at week 195 due to an insufficient number of subjects remaining to obtain reasonable statistical power
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-07